ArticleCell reports. Medicine2024

An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL.

Lars Fabian Prinz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.